Power of scale can help unlock value
and thus more power to choose. As providers compete on this somewhat leveled playing field, they will be pressured to find new ways to
Opinion
As online threats proliferate, brands must protect themselves
In 2014 there were an estimated 3 billion Internet users worldwide, up from 2.8 billion by the end of 2013. The Indexed Web contained at least 4.59 billion pages as of this writing (March 16, 2015). The Worldwide Web is here to stay, and it is clearly not shrinking anytime soon.
At front end and online, gift cards can enhance the mix
In the last five years or so, chain drug stores have made huge progress ramping up their front-of-store offerings.
In skin care, facial masks emerge as the next big thing
Many beauty mavens have fond memories of some of their first product experiments. When we were eager tweens or teens, lip balm, nail polish and fragranced body splashes and sprays were some of the first products most of our mothers let us try.
Pace of change makes the future less clear
Changes within the executive ranks in the chain drug industry are coming at a faster pace these days than at any time in the industry’s history.
Track-and-trace will reshape Rx supply chain
Sweeping changes will begin to transform the pharmaceutical supply chain at the start of 2015, when the first provisions of the Drug Supply Chain Security Act take effect.
In brand marketing, relevance to consumer is critical
the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.
Does ACA meet expectations for pharmacies?
The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment.
How big data will disrupt role of community pharmacy
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins.
Drug chains play to their strengths
As the Christmas selling season begins, it’s becoming increasingly apparent that mass retailers are concerned about business. Not that they have nothing to offer their customers; rather, they have little to offer that’s exciting, new, different, compelling, or even mildly interesting.
Time is right for pharmacy to assert itself
The Republican wave that swept across the country in this month’s midterm elections transformed the political landscape and raised hopes, however fragile, that the gridlock that has come to characterize Washington in recent years might be alleviated, if not completely overcome.
Retail industry in need of more interaction
Mass market retailing, once the scene of an apparently ongoing string of meetings, conferences, exhibit shows and discussions, has morphed into an industry where such gatherings are disappointingly few and far between.
NACDS Foundation functions as a catalyst
A New Prescription for Health Care Improvement” examines a previously murky aspect of the problem: newly prescribed drugs
Other issues take precedence over selling
exactly. Rather, the issue is that retailing, just prior to the Christmas selling season, has become dangerously internalized — and socialized. The talk these days is all about individual companies and the issues that surround them. Perhaps more ominous, much of the discussion revolves around social
A look at the Harvoni/Sovaldi conundrum
Gilead Sciences and its breakthrough work in developing treatments for hepatitis C, the frequently devastating liver disease, have in recent months become the focal point of the debate about the cost and benefits of pharmaceutical products.
Helping consumers navigate the wild world of health apps
The Wild West never lacked for traveling salesmen pushing the newest elixir or snake oil to solve all your medical maladies.